[Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease]
- PMID: 17631710
[Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease]
Abstract
Objective: To study the practical clinical use of the model for end-stage liver disease (MELD) and assess its validity in predicting the short-term (3 mouths) prognosis of patients with chronic severe hepatitis B. The optimal cut-off values of MELD to discriminate between deceased and surviving patients were calculated by using receiver operator characteristic (ROC) curve.
Methods: The clinical information of 139 patients with chronic severe hepatitis B was collected. The patients were divided into two groups, including cirrhosis group and non-cirrhosis group (chronic hepatitis group). All the patients were evaluated with MELD. The death rate was recorded within 3 months.
Results: (1)The scores of MELD in all patients were higher than 20 points. The value of MELD between chronic hepatitis group [(31.34+/-7.00) scores, n=72] and cirrhosis group [(31.97+/-6.82) scores, n=67] had no significant difference(P>0.05). The mortality between the two groups had no significant difference, too. (2)The mortality within 3 months was 58.3% (81/139 cases). The mortality of the patients whose MELD score were 20-30 points, 30-40 points and higher than 40 points were 35.6% (26/73 cases), 76.6% (36/47 cases) and 100% (19/19 cases), respectively. Comparing with the higher scores the mortality was increased at the same MELD score. There were no significant difference in mortality between chronic severe hepatitis B and cirrhosis severe hepatitis B (all P>0.05). The optimal cut-off value of MELD score to predict the prognosis of patients was 31, with sensitivity and specificity were 64.2% and 91.4%, respectively, and c-statistic was 0.809 (95% CI 0.738-0.879).
Conclusion: The onset of chronic liver failure based on cirrhosis might have no important effect on the short-term prognosis. The MELD score can serve as an index of the severity of patients with chronic severe hepatitis B, and it can be used to predict accurately the short-term prognosis.
Similar articles
-
Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.Chin Med J (Engl). 2008 Oct 20;121(20):2065-9. Chin Med J (Engl). 2008. PMID: 19080277
-
[Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease].Zhonghua Gan Zang Bing Za Zhi. 2005 Apr;13(4):249-51. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15850508 Chinese.
-
[Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jul;19(7):412-5. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007. PMID: 17631709 Chinese.
-
Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.J Gastroenterol Hepatol. 2009 Jul;24(7):1179-86. doi: 10.1111/j.1440-1746.2009.05924.x. J Gastroenterol Hepatol. 2009. PMID: 19682192 Review.
-
Ability of King's College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis.Clin Gastroenterol Hepatol. 2016 Apr;14(4):516-525.e5; quiz e43-e45. doi: 10.1016/j.cgh.2015.10.007. Epub 2015 Oct 20. Clin Gastroenterol Hepatol. 2016. PMID: 26499930 Review.
Cited by
-
Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system.Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2673-8. doi: 10.1007/s10096-012-1613-y. Epub 2012 May 9. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22569645
-
An update of the incidence of fulminant hepatitis due to viral agents during pregnancy.Interv Med Appl Sci. 2018 Dec;10(4):210-212. doi: 10.1556/1646.10.2018.40. Interv Med Appl Sci. 2018. PMID: 30792915 Free PMC article. Review.